4.6 Review

Translational control through ribosome heterogeneity and functional specialization

Journal

TRENDS IN BIOCHEMICAL SCIENCES
Volume 47, Issue 1, Pages 66-81

Publisher

CELL PRESS
DOI: 10.1016/j.tibs.2021.07.001

Keywords

-

Funding

  1. Danish Cancer Society [R204-A12532, R231-A1408]
  2. Danish Council for Independent Research (Sapere Aude program)
  3. Novo Nordisk Foundation [NNF18OC0030656]
  4. Lundbeck Foundation [R198-2015-174]

Ask authors/readers for more resources

The concept of ribosome specialization originates from the early days of molecular biology, but has recently gained momentum. Studies have identified distinct ribosome populations in various species and model systems, with some potentially having functional specialization in regulating specific mRNA translation. Further research in this field could reveal a new layer of gene expression control at the translation level, where the ribosome plays a key regulatory role.
The conceptual origins of ribosome specialization can be traced back to the earliest days of molecular biology. Yet, this field has only recently begun to gather momentum, with numerous studies identifying distinct heterogeneous ribosome populations across multiple species and model systems. It is proposed that some of these compositionally distinct ribosomes may be functionally specialized and able to regulate the translation of specific mRNAs. Identification and functional characterization of specialized ribosomes has the potential to elucidate a novel layer of gene expression control, at the level of translation, where the ribosome itself is a key regulatory player. In this review, we discuss different sources of ribosome heterogeneity, evidence for ribosome specialization, and also the future directions of this exciting field.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Targeting RIOK2 ATPase activity leads to decreased protein synthesis and cell death in acute myeloid leukemia

Jan-Erik Messling, Karl Agger, Kasper L. Andersen, Kristina Kromer, Hanna M. Kuepper, Anders H. Lund, Kristian Helin

Summary: Novel therapies are urgently needed for the treatment of acute myeloid leukemia (AML). A study identified RIOK2 as a potential target for AML treatment, as its loss leads to decreased protein synthesis and apoptosis in leukemic cells.

BLOOD (2022)

Article Biology

Rpl24Bst mutation suppresses colorectal cancer by promoting eEF2 phosphorylation via eEF2K

John R. P. Knight, Nikola Vlahov, David M. Gay, Rachel A. Ridgway, William James Faller, Christopher Proud, Giovanna R. Mallucci, Tobias von der Haar, Christopher Mark Smales, Anne E. Willis, Owen J. Sansom

Summary: The Rpl24(Bst) mutation suppresses tumorigenesis and proliferation in a colorectal cancer model with two common patient mutations, by inhibiting translation elongation through eEF2 phosphorylation. This study highlights translation elongation as a potential therapeutic target in CRC and other cancers where the Rpl24(Bst) mutation has a tumor suppressive effect in mouse models.

ELIFE (2021)

Article Cell Biology

PTBP1 promotes hematopoietic stem cell maintenance and red blood cell development by ensuring sufficient availability of ribosomal constituents

Matilda Rehn, Anne Wenzel, Anne-Katrine Frank, Mikkel Bruhn Schuster, Sachin Pundhir, Nanna Jorgensen, Kristoffer Vitting-Seerup, Ying Ge, Johan Jendholm, Magali Michaut, Erwin M. Schoof, Tanja Lyholm Jensen, Nicolas Rapin, Russell T. Sapio, Kasper Langebjerg Andersen, Anders H. Lund, Michele Solimena, Martin Holzenberger, Dimitri G. Pestov, Bo Torben Porse

Summary: Ribosomopathies are a range of disorders that affect protein synthesis and primarily impact hematopoietic stem cells and erythroid development. This study demonstrates that the deletion of poly-pyrimidine-tract-binding protein 1 (PTBP1) in the hematopoietic compartment leads to a condition resembling ribosomopathy. The loss of PTBP1 results in reduced HSC self-renewal, erythroid differentiation, and protein synthesis, along with defects in splicing and ribosome biogenesis.

CELL REPORTS (2022)

Article Biochemistry & Molecular Biology

Creativity as an antidote to research becoming too predictable

Markus Baer, Anja Groth, Anders H. Lund, Katrine Sonne-Hansen

EMBO JOURNAL (2023)

Article Multidisciplinary Sciences

FUS regulates a subset of snoRNA expression and modulates the level of rRNA modifications

Kishor Gawade, Patrycja Plewka, Sophia J. Hafner, Anders H. Lund, Virginie Marchand, Yuri Motorin, Michal W. Szczesniak, Katarzyna D. Raczynska

Summary: FUS is a multifunctional protein involved in various aspects of RNA metabolism. Depletion of FUS leads to differential expression of snoRNAs, which guide the modification of rRNAs and snRNAs. Through our analysis, we observed hypermodification of rRNA species in cells with FUS knockout or FUS mutation related to ALS, suggesting a role of FUS in modulating rRNA modification and translation efficiency/fidelity. This study provides insights into a potential translation-related mechanism underlying ALS development and progression.

SCIENTIFIC REPORTS (2023)

Review Cell Biology

The Role of WNT Pathway Mutations in Cancer Development and an Overview of Therapeutic Options

Wibke Groenewald, Anders H. H. Lund, David Michael Gay

Summary: It is well known that mutations in the WNT-signalling pathway are significant in cancer development. Understanding the role and occurrence of these mutations within the pathway is crucial for developing effective therapeutic strategies. Some cancers have mutations at the receptor level of the pathway, while others have mutations in the cytoplasmic segment, leading to ligand-dependent or ligand-independent pathway activation, respectively. This review explores the driving mutations in cancer and the available therapeutic interventions for each type of mutation, and also discusses a potential new therapeutic avenue targeting the translational apparatus downstream from WNT signalling.

CELLS (2023)

Article Cell Biology

Ribosomal RNA 2'-O-methylation dynamics impact cell fate decisions

Sophia J. Hafner, Martin D. Jansson, Kubra Altinel, Kasper L. Andersen, Zehra Abay-Norgaard, Patrice Menard, Martin Fontenas, Daniel M. Sorensen, David M. Gay, Frederic S. Arendrup, Disa Tehler, Nicolai Krogh, Henrik Nielsen, Matthew L. Kraushar, Agnete Kirkeby, Anders H. Lund

Summary: Translational regulation plays a crucial role in pluripotency maintenance and cell differentiation. This study reveals ribosome heterogeneity through rRNA 2'-O-methylation during early development and differentiation, indicating a direct role for ribosomes in regulating translation during cell fate acquisition.

DEVELOPMENTAL CELL (2023)

Editorial Material Biochemistry & Molecular Biology

Making nucleic acid structures and schematics

Lien B. Lai, Venkat Gopalan, Martin D. Jansson, Qi Chen, Xudong Zhang, Maik Wolfram-Schauerte, Katharina Hofer

Summary: This article focuses on the importance of nucleic acids in biochemistry, specifically RNA, and discusses the generation of figures representing their structures. Several authors provide insights into the factors to consider when creating such figures, preferred software, and examples from their own research.

TRENDS IN BIOCHEMICAL SCIENCES (2023)

Article Endocrinology & Metabolism

Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target

Johan Vande Voorde, Rory T. Steven, Arafath K. Najumudeen, Catriona A. Ford, Alex Dexter, Ariadna Gonzalez-Fernandez, Chelsea J. Nikula, Yuchen Xiang, Lauren Ford, Stefania Maneta Stavrakaki, Kathryn Gilroy, Lucas B. Zeiger, Kathryn Pennel, Phimmada Hatthakarnkul, Efstathios A. Elia, Ammar Nasif, Teresa Murta, Eftychios Manoli, Sam Mason, Michael Gillespie, Tamsin R. M. Lannagan, Nikola Vlahov, Rachel A. Ridgway, Colin Nixon, Alexander Raven, Megan Mills, Dimitris Athineos, Georgios Kanellos, Craig Nourse, David M. Gay, Mark Hughes, Amy Burton, Bin Yan, Katherine Sellers, Vincen Wu, Kobe De Ridder, Engy Shokry, Alejandro Huerta Uribe, William Clark, Graeme Clark, Kristina Kirschner, Bernard Thienpont, Vivian S. W. Li, Oliver D. K. Maddocks, Simon T. Barry, Richard J. A. Goodwin, James Kinross, Joanne Edwards, Mariia O. Yuneva, David Sumpton, Zoltan Takats, Andrew D. Campbell, Josephine Bunch, Owen J. Sansom

Summary: In this study, the potential of untargeted metabolomics as a stratification tool for colorectal cancer (CRC) was investigated. The researchers presented a comprehensive pipeline to uncover metabolic vulnerabilities in CRC based on its genetic origin. Perturbations in methionine metabolism linked to APC deficiency were observed, and adenosylhomocysteinase was identified as an actionable therapeutic target.

NATURE METABOLISM (2023)

No Data Available